Navigation Links
CryoLife's Fully Diluted Earnings Per Share Increased 71 Percent to $0.12 in Third quarter of 2008 from $0.07 in Third quarter of 2007
Date:10/30/2008

in tissue processing revenues was due primarily to increased demand for the Company's cardiac and vascular processed tissues, the introduction of the CryoValve(R) SG pulmonary human heart valve and, to a lesser extent, price increases, partially offset by a decline in orthopaedic tissue processing revenues.

Combined cardiac and vascular tissue processing revenues in the third quarter of 2008 increased 31 percent to $14.2 million compared to $10.8 million in the third quarter of 2007. Combined cardiac and vascular tissue processing revenues in the first nine months of 2008 increased 26 percent to $40.7 million compared to $32.4 million in the first nine months of 2007.

Revenues from the distribution of CryoValve SG pulmonary human heart valves were $1.7 million and $3.4 million, respectively, for the three and nine months ended September 30, 2008.

Orthopaedic tissue processing revenues in the third quarter of 2008 decreased to $38,000 from $566,000 in the third quarter of 2007. Orthopaedic tissue processing revenues in the first nine months of 2008 decreased to $662,000 from $3.7 million in the first nine months of 2007. These revenue declines were anticipated as the Company discontinued procuring and processing orthopaedic tissue in January of 2007 pursuant to the exchange and service agreement signed with a third party in December 2006.

BioGlue(R) Surgical Adhesive revenues were $11.6 million for the third quarter of 2008 compared to $10.3 million in the third quarter of 2007, an increase of 13 percent. BioGlue revenues were $36.5 million for the first nine months of 2008 compared to $32.4 million for the first nine months of 2007, an increase of 13 percent.

U.S. BioGlue revenues were $8.1 million and $7.4 million in the third quarter of 2008 and 2007, respectively. U.S. BioGlue revenues were $25.8 million and $23.4 million in the first nine months of 2008 and 2007, respectively. International BioGlue revenues were $3.5 million an
'/>"/>

SOURCE CryoLife, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. CeloNova BioSciences Announces Worlds First Line of Fully Color-Coded Embolic Particles at CIRSE: Embozene(TM) Color-Advanced Microspheres
2. Concuity Announces the Launch of Its New Fully Accessible Website - Concuity.Com
3. EpiStem Successfully Complete First Year of Mucositis Tests for NIH Biodefence Programme
4. Life on Mars pregnancy test successfully launched
5. Oridion Launches its Fully Integrated Remote Monitoring System and SARA Software for Improved Patient Safety
6. ARIUS announces cancer stem cell antibody program successfully completes first toxicology study
7. Nikon Instruments Launches New Eclipse Ti-E Fully-Integrated, Motorized Inverted Microscope
8. Phase I Safety and Tolerability Study With EVT 302 Successfully Completed
9. Abbott Announces Approval of First Fully Automated Blood Screening Test for HTLV-I/HTLV-II
10. Nikon Instruments Launches Fully-Automated A1 Confocal Laser Microscope Series
11. The Lancet Publishes Results From Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... LOUIS , June 2, 2015   ... Life Science and Technology company, announced today it ... Science to launch genetically engineered human neural ... advance the research of neurological diseases. These new ... provide unique and versatile tools for the study ...
(Date:6/2/2015)... 2015 Through rare discovery of new ... Corporation is enabling World Scientists to actually see, ... sample, displaying the full nature (position, shape, size, number) ... Jeff Porter, Co-Founder of the Yancy Corporation, says, "Our ... rare. They come once in a lifetime, if at ...
(Date:6/1/2015)... , June 1, 2015  Turing Pharmaceuticals ... Eliseo Oreste Salinas , MD, MSc,  has joined ... Dr. Salinas, who holds a medical ... brings a record of significant accomplishments in the ... Dr. Salinas has played a leadership ...
(Date:6/1/2015)... -- About Bio-alcohols Bio-alcohols are organic ... Bio-alcohols are primarily used in the transportation sector. For ... gasoline in cars. Technavio,s analysts forecast the global bio-alcohols ... over the period 2014-2019. Covered in ... into five: transportation, infrastructure, medical, and others. Technavio,s report, ...
Breaking Biology Technology:Sigma-Aldrich to Launch XCell Science Genetically Engineered iPSC-Derived Neural Disease Cells 2Sigma-Aldrich to Launch XCell Science Genetically Engineered iPSC-Derived Neural Disease Cells 3Scientists Eying Rare Discovery Of New Physics & Light Microscope Technology 2Turing Pharmaceuticals Names Eliseo Salinas, MD and MSc, President of Research and Development 2Turing Pharmaceuticals Names Eliseo Salinas, MD and MSc, President of Research and Development 3Global Bio-alcohols Market 2015-2019 2
... -- BEIJING, Aug. 24 /PRNewswire-Asia/ -- ... ... ... Results are keyed by longUrl, so we need to grab the first one. for (var r ...
... Kendle (Nasdaq: KNDL ), a ... the appointment of Jeffrey M. Zucker as Senior ... provide global leadership for the development and implementation ... retention and support the timely and efficient delivery ...
... Based on its recent analysis of the algae ... the 2010 Global Algae Biofuels Green Excellence in Technology ... possible solution to two crucial issues plaguing consumers – ... commercial production of algae biofuels needs a cost-effective technology ...
Cached Biology Technology:Novel Stem Cell Therapy From Cellonis Biotechnologies Can Help Children With Diabetes Get Back Their Normal Lives 2Novel Stem Cell Therapy From Cellonis Biotechnologies Can Help Children With Diabetes Get Back Their Normal Lives 3Novel Stem Cell Therapy From Cellonis Biotechnologies Can Help Children With Diabetes Get Back Their Normal Lives 4Novel Stem Cell Therapy From Cellonis Biotechnologies Can Help Children With Diabetes Get Back Their Normal Lives 5Novel Stem Cell Therapy From Cellonis Biotechnologies Can Help Children With Diabetes Get Back Their Normal Lives 6Kendle Appoints Jeffrey M. Zucker to Lead Global Patient Recruitment Efforts 2Frost & Sullivan Recognizes Algasol Renewables for its Micro Algae Biomass Production System 2Frost & Sullivan Recognizes Algasol Renewables for its Micro Algae Biomass Production System 3Frost & Sullivan Recognizes Algasol Renewables for its Micro Algae Biomass Production System 4
(Date:4/21/2015)... High crime rate, increasing ... access control systems market in Saudi Arabia ... published report by TechSci Research " Saudi Arabia Access Control ... systems market in Saudi Arabia ... control systems market in the Kingdom is growing at ...
(Date:4/20/2015)... 20, 2015 The announcement comes ... Glenbeigh Records Management (GRM), Ireland,s foremost ... Bank. Having built up an impressive track record of clients ... player within the records management sector in Dubai ... is GCC staffbase and employ a further eight staff members ...
(Date:4/14/2015)... , April 14, 2015  HYPR Corp. ... Online (FIDO ® ) Alliance tm , an ... FIDO members commit to share technology and collaborate ... that are interoperable, more secure and private, and ... biometric identity verification that protects sensitive user information ...
Breaking Biology News(10 mins):Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3
... This week in the journal Science , Swedish and ... year old fossil fishes, revealed by unique fossils from a ... understand how neck muscles and abdominal muscles "abs" ... of rattling skeletons. Bones and teeth fossilize far more easily ...
... 12 June 2013: Data presented at EULAR 2013, the ... that novel antibody biomarkers could significantly improve diagnosis in ... UH-RA.1, UH-RA.9, UH-RA.14 and UH-RA.21 were investigated; as ... were present in both early and seronegative disease, ...
... test previously developed to measure a toxin found in ... toxin in people suffering from spinal cord injuries and ... , The toxin, called acrolein, is produced in the ... of biochemical events thought to worsen the injury,s severity. ...
Cached Biology News:Testing method promising for spinal cord injuries, multiple sclerosis 2Testing method promising for spinal cord injuries, multiple sclerosis 3
... calcium binding proteins such as calmodulin and troponin ... and beta chain whereas S100B is composed of ... expressed in the antigen presenting cells such as ... cells in the paracortex of lymph nodes. ...
LEAF™ Purified anti-human/mouse/rat ICOS...
Peptide-affinity Purified Polyclonal Antibody to MTR...
Purified anti-eIF-4E...
Biology Products: